Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
Por um escritor misterioso
Descrição
Frontiers The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors
The Resurgence of Antibody Drug Conjugates in Cancer Therapeutics: Novel Targets and Payloads
Construction and characterization of mAb–Ang2 conjugates. (A)
Antibody drug conjugates in brain tumors – new kids on the block?
Cells, Free Full-Text
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
Vaccines, Free Full-Text
Cancers, Free Full-Text
Construction and characterization of dual-drug ADCs. a Deconvoluted
Antibody–drug conjugates for cancer therapy - The Lancet Oncology
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches, Journal of Nanobiotechnology
Structure–Activity Relationships of Antibody-Drug Conjugates: A Systematic Review of Chemistry on the Trastuzumab Scaffold
The ever-expanding landscape of antibody-drug conjugates (ADCs) in solid tumors: A systematic review - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
